Martin Lundblad (Former)
1 – 10 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
In vivo electrochemical studies of optogenetic control of glutamate signaling measured using enzyme-based ceramic microelectrode arrays
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Modeling Parkinson’s disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain
(2017) In Proceedings of the National Academy of Sciences of the United States of America 114(39). p.8284-8293
- Contribution to journal › Article
- 2016
-
Mark
DREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 Receptor
- Contribution to journal › Article
- 2015
-
Mark
Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.
- Contribution to journal › Article
- 2014
-
Mark
Highly efficient generation of induced neurons from human fibroblasts that survive transplantation into the adult rat brain.
- Contribution to journal › Article
-
Mark
Dynamic changes in dopamine neuron function after DNSP-11 treatment: Effects in vivo and increased ERK 1/2 phosphorylation in vitro.
- Contribution to journal › Article
- 2013
-
Mark
Striatal Glutamate Release in L-DOPA-Induced Dyskinetic Animals
- Contribution to journal › Article
-
Mark
TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity.
- Contribution to journal › Article
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
- Contribution to journal › Article
- 2012
-
Mark
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons.
- Contribution to journal › Article
